| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GW 441756 | GDSC1000 | pan-cancer | AAC | 0.065 | 0.09 |
| mRNA | Epothilone B | GDSC1000 | pan-cancer | AAC | -0.064 | 0.09 |
| mRNA | CEP-701 | GDSC1000 | pan-cancer | AAC | -0.06 | 0.09 |
| mRNA | RAF265 | FIMM | pan-cancer | AAC | 0.35 | 0.09 |
| mRNA | BRD-K41334119 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.09 |
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | -0.065 | 0.09 |
| mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | -0.081 | 0.09 |
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | 0.1 | 0.09 |
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.055 | 0.09 |
| mRNA | QS11 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.09 |